BRISBANE, Calif., March 9 InterMune, Inc. (Nasdaq: ITMN) announced that it will hold a webcast of a live conference call today at 5:00 p.m. EST to discuss the outcome of today's Pulmonary-Allergy Drugs Advisory Committee (PADAC). The committee was convened by the U.S. Food and Drug Administration to review and discuss the company's New Drug Application (NDA) for pirfenidone for the treatment of patients with idiopathic pulmonary fibrosis (IPF).
Advertisement
Conference Call and Webcast Details
Investors and media may participate in the conference call by dialing 888-799-0528 (U.S.) or 973-200-3372 (international), conference ID# 61659499. A replay of the webcast and teleconference will be available approximately three hours after the call.
Advertisement
To access the webcast, please log on to the company's website at www.intermune.com at least 15 minutes prior to the start of the call to ensure adequate time for any software downloads that may be required.
The teleconference replay will be available for 10 business days following the call and can be accessed by dialing 800-642-1687 (U.S.) or 706-645-9291 (international), and entering the conference ID# 61659499.
SOURCE InterMune, Inc.
